Evidence map›Paper›PMID 41961126›Full record

ArticleJournal of pharmacokinetics and pharmacodynamics2026

A structure-preserving hybrid learning framework for compartmental pharmacokinetic models.

Hanan Al Lawati, Mohamed Al-Lawatia

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of pharmacokinetics and pharmacodynamics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hanan Al LawatiPharmacy Program, Oman College of Health Sciences, Muscat, Sultanate of Oman.
Mohamed Al-LawatiaDepartment of Mathematics, Sultan Qaboos University, P.O. Box 36, Al-Khodh, 123, Sultanate of Oman. allawati@squ.edu.om.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmacokinetic (PK) models are widely used in drug development and dose planning, but they often face a trade-off between interpretability and flexibility. Traditional physiology-based PK models are transparent but may be too simple to capture complex or nonlinear behavior, while AI models are more flexible but can violate basic physical constraints such as nonnegativity or mass balance. In this work, we propose a constrained hybrid AI-PK approach in which small AI components are embedded within the PK equations as bounded corrections to mechanistic rates. The correction network is constructed to be internally conservative across compartments and to act as a controlled perturbation of the base model. We provide a simple mathematical analysis showing that this design preserves key qualitative properties, including boundedness and, under suitable conditions, positivity and stability. Numerical experiments on simulated and reported PK datasets show that the constrained hybrid model improves prediction accuracy and yields more stable extrapolation than both purely mechanistic and unconstrained hybrid models, while respecting the underlying physical structure.

Indexed as

Machine LearningModels, BiologicalPharmacokineticsAlgorithmsAnimalsComputer SimulationHumansNonlinear DynamicsBounded perturbationsCompartmental dynamical systemsMass conservationPharmacokinetic modelingStructure-preserving modeling

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.